Low Albumin and Elevated FIB-4 Are Associated With Adverse Outcomes After the Fontan Procedure
- 19 June 2026
- journal article
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 35 (9) , 1348-1356
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Platelet slope and long-term clinical outcomes in children and adults with Fontan-associated liver diseaseHepatology International, 2025
- Clinical characteristics and outcomes in middle-aged Fontan patientsInternational Journal of Cardiology, 2024
- Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adultsDigestive and Liver Disease, 2024
- Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLDHepatology Communications, 2021
- Life After Surviving Fontan Surgery: A Meta-Analysis of the Incidence and Predictors of Late DeathHeart, Lung and Circulation, 2018
- Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §ΔHepatology, 2010
- Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis BDigestive and Liver Disease, 2008
- FIB-4Hepatology, 2007
- MELD-XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapyLiver Transplantation, 2006
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006